Cytosorbents Corp
CTSO
52 hedge funds and large institutions have $22M invested in Cytosorbents Corp in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 6 closing their positions.
1,182% more capital inflows, than outflows
Capital inflows: $7.75M | Capital outflows: $604K
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
3.71% more ownership
Funds ownership: 34.35% → 38.06% (+3.7%)
2% more funds holding
Funds holding: 51 → 52 (+1)
0% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
+$3.12M |
| 2 |
Granahan Investment Management
Waltham,
Massachusetts
|
+$3.07M |
| 3 |
Avenir Corporation
Alexandria,
Virginia
|
+$496K |
| 4 |
Skylands Capital
Milwaukee,
Wisconsin
|
+$460K |
| 5 |
Renaissance Technologies
New York
|
+$83.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$178K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$108K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$57.7K |
| 4 |
CM
CM Management
Gulf Breeze,
Florida
|
-$52K |
| 5 |
Eudaimonia Partners
Winchester,
Tennessee
|
-$44.2K |
CTSO Hedge Fund Activity: Q4 2023 in Review
52 of the 6,876 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q4 2023, worth a combined $22M — down 23% from $28.7M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new CTSO positions and 6 closed out — a net gain of 2 holders — while 14 added to existing stakes and 14 trimmed.
The largest buyer was Neuberger Berman Group, adding an estimated $3.12M. The largest seller was Millennium Management, cutting an estimated $178K.
- 52 institutional investors held Cytosorbents Corp (CTSO) as of Q4 2023, up from 51 in Q3 2023.
- Funds reported $22M of Cytosorbents Corp stock for Q4 2023, down 23% quarter-over-quarter.
- 8 funds opened new Cytosorbents Corp positions in Q4 2023 and 6 closed out, a net change of +2 holders.
- The largest Cytosorbents Corp buyer in Q4 2023 was Neuberger Berman Group, an estimated $3.12M added.
- The largest Cytosorbents Corp seller in Q4 2023 was Millennium Management, an estimated $178K sold.
Based on aggregated 13F filings for Q4 2023.